What is CME Group's proceeds from debt financing, net of issuance costs?

CME Group (CME) reported proceeds from debt financing, net of issuance costs of $0.00 in Q1 2026.

Proceeds from Debt Financing, Net of Issuance Costs

CME Group Proceeds from Debt Financing, Net of Issuance Costs decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $742.30M to $0.00.

Analysis

StatementCash Flow Statement

SectionFinancing

First reportedQ1 2020

Last reportedQ1 2026Apr 24, 2026

Metric ID: gild_proceeds_from_debt_financing_net

Historical Data

14 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q1 '26
Value	$0.00	$0.00	$0.00	$742.70M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$742.30M	$0.00
QoQ Change	—	—	—	—	-100.0%	—	—	—	—	—	—	—	—	-100.0%
YoY Change	—	—	—	—	-100.0%	—	—	—	—	—	—	—	—	-100.0%

Range$0.00 – $742.70M

Avg YoY Growth-100.0%

Median YoY Growth-100.0%

Frequently Asked Questions

What is CME Group's proceeds from debt financing, net of issuance costs?: CME Group (CME) reported proceeds from debt financing, net of issuance costs of $0.00 in Q1 2026.
How has CME Group's proceeds from debt financing, net of issuance costs changed year-over-year?: CME Group's proceeds from debt financing, net of issuance costs decreased by 100.0% year-over-year, from $742.30M to $0.00.